These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 6848792)
1. Choice of blood substitutes in Chicago. Cowart VS JAMA; 1983 Jan; 249(2):164, 166. PubMed ID: 6848792 [No Abstract] [Full Text] [Related]
2. Blood substitutes: two ways to get there. Cowart VS JAMA; 1983 Jan; 249(2):159, 163-4. PubMed ID: 6848791 [No Abstract] [Full Text] [Related]
3. Blood substitutes: has the right solution been found? Lancet; 1986 Mar; 1(8483):717-8. PubMed ID: 2870227 [No Abstract] [Full Text] [Related]
4. Which is the foreseeable clinical application of oxygen-carrying blood substitutes (fluorocarbons and hemoglobin solutions)? Which impact are they likely to have on the activity of blood services? Vox Sang; 1982 Feb; 42(2):97-109. PubMed ID: 7064434 [No Abstract] [Full Text] [Related]
8. Blood component therapy in anaesthetic practice. Blajchman MA; Herst R; Perrault RA Can Anaesth Soc J; 1983 Jul; 30(4):382-9. PubMed ID: 6347352 [No Abstract] [Full Text] [Related]
9. Hemodilution and myocardial oxygen supply. The influence of fluosol-DA. Vogel H; Günther H; Harrison DK; Anderer W; Kessler M; Peter K Adv Exp Med Biol; 1989; 248():653-61. PubMed ID: 2782181 [No Abstract] [Full Text] [Related]
10. Blood and plasma substitutes--plasma expansion and oxygen transport properties. Waxman K; Tremper KK; Mason GR West J Med; 1985 Aug; 143(2):202-6. PubMed ID: 2412350 [TBL] [Abstract][Full Text] [Related]
11. FDA committee questions Fluosol efficacy; US approval not imminent. Marwick C JAMA; 1983 Nov; 250(19):2585-6. PubMed ID: 6632147 [No Abstract] [Full Text] [Related]
12. Tissue oxygenation by fluorocarbons. Faithfull NS; Fennema M; Erdmann W; Lapin R; Smith AR; Van Alphen W; Essed CE; Trouwborst A Adv Exp Med Biol; 1984; 180():569-80. PubMed ID: 6534130 [No Abstract] [Full Text] [Related]
13. Cold protected hearts extract oxygen from Fluosol-DA during cardiopulmonary bypass. Gartman DM; McDonagh PF; Geha AS Adv Exp Med Biol; 1984; 180():443-50. PubMed ID: 6534118 [No Abstract] [Full Text] [Related]
14. Can "artificial blood' live up to public billing? Cowart VS JAMA; 1982 Feb; 247(8):1104-5. PubMed ID: 7057595 [No Abstract] [Full Text] [Related]
15. Stability of perfluorocarbon blood substitutes determined by sedimentation field-flow fractionation. Yang FS; Caldwell KD; Giddings JC; Astle L Anal Biochem; 1984 May; 138(2):488-94. PubMed ID: 6742424 [TBL] [Abstract][Full Text] [Related]
16. The protective effect of mannitol and perfluorochemicals on hemorrhagic infarction: an experimental study. Kagawa S; Koshu K; Yoshimoto T; Suzuki J Surg Neurol; 1982 Jan; 17(1):66-70. PubMed ID: 6803373 [No Abstract] [Full Text] [Related]
17. Effects of different oxygen concentrations during hemodilution with Fluosol or LMW-Dextran in rabbits. Beisbarth H; Madjidi A; Frey R Prog Clin Biol Res; 1983; 122():373-80. PubMed ID: 6192450 [No Abstract] [Full Text] [Related]
19. Development and clinical application of perfluorochemical artificial blood. Ohyanagi H; Saitoh Y Int J Artif Organs; 1986 Sep; 9(5):363-8. PubMed ID: 3781670 [TBL] [Abstract][Full Text] [Related]
20. [Chemical modification of hemoglobin and blood substitutes]. Bai JS; Bu FR Sheng Li Ke Xue Jin Zhan; 2001 Jan; 32(1):71-3. PubMed ID: 12545784 [No Abstract] [Full Text] [Related] [Next] [New Search]